Published in J Speech Hear Res on December 01, 1984
Attention effects on auditory scene analysis in children. Neuropsychologia (2008) 1.00
Dynamics of infant cortical auditory evoked potentials (CAEPs) for tone and speech tokens. Int J Pediatr Otorhinolaryngol (2013) 0.82
Relationship between speech perception in noise and phonological awareness skills for children with normal hearing. Ear Hear (2010) 0.81
Assessment: scientific foundation. Trends Amplif (1999) 0.75
The audiologic assessment of the young pediatric patient: the clinic. Trends Amplif (1999) 0.75
Refining Stimulus Parameters in Assessing Infant Speech Perception Using Visual Reinforcement Infant Speech Discrimination: Sensation Level. J Am Acad Audiol (2015) 0.75
Effects of Self-Generated Noise on Estimates of Detection Threshold in Quiet for School-Age Children and Adults. Ear Hear (2016) 0.75
Rodent auditory perception: Critical band limitations and plasticity. Neuroscience (2015) 0.75
Auditory System Development and Dysfunction: What Do We Really Know about Childhood Hearing Loss? Trends Amplif (1999) 0.75
Microbiological and clinical evaluation of the isolator lysis-centrifugation blood culture tube. J Clin Microbiol (1983) 5.77
Anaerobic bacteremia. Mayo Clin Proc (1972) 4.79
Optimal testing parameters for blood cultures. Clin Infect Dis (2004) 3.17
The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol (1980) 2.93
Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67
Anaerobic bacteremia: decreasing rate over a 15-year period. Rev Infect Dis (1991) 2.65
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA (1997) 2.52
The antimicrobial removal device. A microbiological and clinical evaluation. Am J Clin Pathol (1982) 2.40
Antimicrobial susceptibilities of species of viridans streptococci. J Infect Dis (1979) 2.37
N-Substituted 2-(2,6-dinitrophenylamino)propanamides: novel prodrugs that release a primary amine via nitroreduction and intramolecular cyclization. J Med Chem (1999) 2.13
Infective endocarditis caused by HACEK microorganisms. Annu Rev Med (1997) 2.03
Antibiotic therapy for otitis media with effusion. A response from Pittsburgh. JAMA (1993) 2.01
Prospective evaluation of the risk of bacteremia associated with transesophageal echocardiography. Circulation (1991) 1.99
Ceftriaxone sodium therapy of penicillin G-susceptible streptococcal endocarditis. JAMA (1992) 1.97
Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med (1990) 1.96
DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogues of pibenzimol (Hoechst 33258) J Med Chem (1994) 1.93
Erythromycin: a microbial and clinical perspective after 30 years of clinical use (2). Mayo Clin Proc (1985) 1.93
G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action. Nat Neurosci (1999) 1.92
Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1). Mayo Clin Proc (1985) 1.91
Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon. J Clin Invest (1975) 1.91
Prosthetic valve endocarditis. Ann Intern Med (1975) 1.78
Efficacy of amoxicillin with and without decongestant-antihistamine for otitis media with effusion in children. Results of a double-blind, randomized trial. N Engl J Med (1987) 1.77
Correlation of beta blockade with serum practolol levels after oral administration. Clin Pharmacol Ther (1972) 1.74
Efficacy of antimicrobial prophylaxis and of tympanostomy tube insertion for prevention of recurrent acute otitis media: results of a randomized clinical trial. Pediatr Infect Dis J (1992) 1.73
Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med (1984) 1.64
Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. J Infect Dis (1996) 1.63
Traveling toothpicks. Mayo Clin Proc (1983) 1.61
Analysis of 281,797 consecutive blood cultures performed over an eight-year period: trends in microorganisms isolated and the value of anaerobic culture of blood. Clin Infect Dis (1997) 1.60
Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol (1991) 1.59
Symposium on infective endocarditis. III. Endocarditis due to gram-negative bacteria. Report of 56 cases. Mayo Clin Proc (1982) 1.57
Tracheostomy: a risk factor for mediastinitis after cardiac operation. Ann Thorac Surg (2001) 1.51
Age-related hearing loss, vitamin B-12, and folate in elderly women. Am J Clin Nutr (1999) 1.49
Blood flow failure as a major determinant in the antitumor action of flavone acetic acid. J Natl Cancer Inst (1989) 1.49
Clinical significance of Pseudallescheria boydii: a review of 10 years' experience. Mayo Clin Proc (1985) 1.43
Toxic shock syndrome, a newly recognized disease entity. Report of 11 cases. Mayo Clin Proc (1980) 1.41
Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci. Antimicrob Agents Chemother (1982) 1.41
Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin. Am J Med (1987) 1.40
Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin. JAMA (1981) 1.39
Prosthetic valve endocarditis. Mayo Clin Proc (1982) 1.36
Haemophilus endocarditis. Report of 14 patients. Mayo Clin Proc (1977) 1.35
Tetracyclines, chloramphenicol, erythromycin, and clindamycin. Mayo Clin Proc (1977) 1.34
Developmental changes in speech discrimination in infants. J Speech Hear Res (1977) 1.31
Vancomycin therapy for infective endocarditis. Rev Infect Dis (1982) 1.30
Synergy of penicillin and decreasing concentration of aminoglycosides against enterococci from patients with infective endocarditis. Antimicrob Agents Chemother (1980) 1.29
Treatment of streptococcal infective endocarditis. Am J Med (1985) 1.28
Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma. Am J Ophthalmol (1998) 1.25
Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease. Southeastern Minnesota Streptococcal Working Group. Clin Infect Dis (1998) 1.24
In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis. Antimicrob Agents Chemother (1987) 1.23
Candida lusitaniae--an opportunistic pathogen. Diagn Microbiol Infect Dis (1985) 1.23
Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med (1991) 1.23
Pulmonary disease in the immunocompromised host (2). Mayo Clin Proc (1985) 1.21
Aerococcus viridans endocarditis. Mayo Clin Proc (1984) 1.17
Linguistic experience and phonemic perception in infancy: a crosslinguistic study. Child Dev (1979) 1.16
Infective endocarditis--a 25 year overview of diagnosis and therapy. J Am Coll Cardiol (1983) 1.16
Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs. Br J Cancer (1998) 1.16
Viral and epidemiologic studies of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg (1983) 1.14
Anticoagulant therapy and central nervous system complications in patients with prosthetic valve endocarditis. Circulation (1978) 1.14
Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines. J Med Chem (1990) 1.13
Infective endocarditis. Olmsted County, Minnesota, 1950 through 1981. JAMA (1985) 1.12
Studies of the reputed augmentation of the cardiovascular effects of catecholamines in patients with spontaneous hyperthyroidism. J Pharmacol Exp Ther (1972) 1.12
Visual reinforcement of head-turn responses in infants under 12 months of age. J Speech Hear Disord (1977) 1.11
Correlation between immune and vascular activities of xanthenone acetic acid antitumor agents. Oncol Res (1994) 1.11
Efficacy of myringotomy with and without tympanostomy tubes for chronic otitis media with effusion. Pediatr Infect Dis J (1992) 1.11
Leukocyte chemotaxis in diabetic patients and their nondiabetic first-degree relatives. Diabetes (1976) 1.10
Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis. Antimicrob Agents Chemother (1993) 1.09
Interaction of the antitumor drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines with nucleic acids. Mol Pharmacol (1981) 1.09
Pulmonary disease in the immunocompromised host. 1. Mayo Clin Proc (1985) 1.09
Adverse effects of vancomycin administered in the perioperative period. Mayo Clin Proc (1986) 1.08
Considerations for the design of nitrophenyl mustards as agents with selective toxicity for hypoxic tumor cells. J Med Chem (1986) 1.07
An immunological assessment of patients with anorexia nervosa. Am J Clin Nutr (1981) 1.07
Management of complications of infective endocarditis. Mayo Clin Proc (1982) 1.06
Ketolide treatment of Haemophilus influenzae experimental pneumonia. Antimicrob Agents Chemother (1999) 1.06
Group B streptococcal infective endocarditis. Arch Intern Med (1985) 1.06
The relationship of idiopathic sudden hearing loss to diabetes mellitus. Laryngoscope (1982) 1.05
Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits. Antimicrob Agents Chemother (1992) 1.04
Two-vessel coronary artery dissection in the peripartum period. Case report and literature review. Angiology (1994) 1.04
Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells. J Med Chem (1992) 1.04
Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis (2010) 1.04
Infective endocarditis caused by Actinobacillus actinomycetemcomitans: report of four cases. Mayo Clin Proc (1980) 1.03
Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis. Arch Intern Med (1989) 1.03
A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells. Anal Biochem (1984) 1.02
Antibiotic treatment of infective endocarditis. Annu Rev Med (1983) 1.02
Clinical significance of postmortem cultures. Arch Pathol (1972) 1.02
Ten years of extracorporeal membrane oxygenation: neurodevelopmental outcome. Pediatrics (1991) 1.01
Effects of beta-adrenergic receptor blockade in normal subjects before, during, and after triiodothyronine-induced hypermetabolism. J Clin Invest (1966) 1.01
Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards. J Med Chem (1993) 1.00
Empiric therapy with moxalactam alone in patients with bacteremia. Mayo Clin Proc (1984) 1.00
Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia. Expert Opin Investig Drugs (2000) 1.00
Myringotomy with and without tympanostomy tubes for chronic otitis media with effusion. Arch Otolaryngol Head Neck Surg (1989) 0.99
Multicellular membranes as an in vitro model for extravascular diffusion in tumours. Br J Cancer Suppl (1996) 0.99
Bioreducible mustards: a paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs). Cancer Metastasis Rev (1993) 0.99
[14C]urea breath test for diagnosis of Helicobacter pylori. Dig Dis Sci (1990) 0.98
Why treat sudden hearing loss. Am J Otol (1984) 0.98
Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group. Clin Infect Dis (1998) 0.98
An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours. Br J Cancer (1997) 0.98
Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women. J Antimicrob Chemother (1986) 0.98
Mechanisms of enhancement of the antitumour activity of melphalan by the tumour-blood-flow inhibitor 5,6-dimethylxanthenone-4-acetic acid. Cancer Chemother Pharmacol (1997) 0.98
Prospective evaluation of the utility of molecular techniques for diagnosing nosocomial transmission of multidrug-resistant tuberculosis. Mayo Clin Proc (1996) 0.97
Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins. Anticancer Drug Des (1998) 0.97
NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation. Int J Radiat Oncol Biol Phys (1992) 0.96